June 2010

LRI Extols Power of Scientific Innovation at International Lupus Congress

Supports Bold and Pioneering Exploration in Lupus and Autoimmunity

The LRI reinforces its call for cutting-edge science as the path to a cure for the complex autoimmune disease of lupus as it sponsors key programming in innovative research at the international congress beginning in Vancouver today.

“This is a very exciting time in global lupus research, as we witness results of the incredible power of innovation in cracking the mysteries of this disease,” said LRI President Margaret G. Dowd in preparation for the triennial meeting, which assembles top lupus researchers, physicians, and clinical trial leaders to share and assess key developments in the field.

The LRI’s Cutting Edge of Lupus Research Plenary Session kicks off the full meeting with presentations of the world’s top innovative lupus research abstracts.

Speaking at the plenary session this afternoon:

  • University of California at San Francisco’s Matthias Wabl, PhD, who explores a concept that remnants of ancient viruses in our genome may be what triggers the lupus immune system attack—and that removing them may be key to stopping the disease process.

  • University of Chicago’s Timothy Niewold, MD, FACR, who presents his innovative model for linking genetic associations with lupus.

  • University of Michigan’s Marianna Kaplan, MD, whose explanation for why vascular damage occurs in so many people with lupus is a novel one.

  • Dr. Qingyu Cheng, who has traveled from Germany to present a cutting-edge hypothesis on lupus nephritis.

Other innovative international abstract presenters today include Dr. Ram Raj Singh at the University of Cincinnati, Dr. Sahena Haque from the UK, and Dr. Patrice Decker from Germany. 

“So much about this complex and surprising disease is not yet understood,” said Dowd. “Over the past decade the LRI has encouraged scientists to think creatively and outside of the box, taking risks and bringing new ideas, new questions, and new eyes to bear on the complexities of lupus and autoimmunity.”

“The LRI is a global leader in identifying bold and promising scientific hypotheses in lupus—and its approach is working, demonstrating the power of innovation to lead the path to discovery,” said Michel Nussenzweig, MD, PhD, the Sherman Fairchild Professor at Rockefeller University and a member of the LRI Scientific Advisory Board.

 

 

About the LRI
The nation’s only nonprofit singularly dedicated to novel research in lupus, we champion innovation and scientific risk-taking in the hunt for solutions to this complex and dangerous autoimmune disease.

Lupus Research Institute
330 Seventh Avenue, Suite 1701, New York, NY 10001
T: 212.812.9881 F: 212.545.1843
e-mail: Lupus@LupusNY.org

www.LupusResearchInstitute.org